| Dr Luis F Beaz Rivera, MD | |
|
Mansion Real, Calle Rey Fernando 129, Cotto Laurel, PR 00780 | |
| (787) 812-3571 | |
| Not Available |
| Full Name | Dr Luis F Beaz Rivera |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | Mansion Real, Cotto Laurel, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215906995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 10634 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| San Luke's Memorial Hospital Inc | Ponce, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Providers Group, P.s.c. | 1052590270 | 3 |
| Saint Lukes Memorial Hospital Inc | 1456376599 | 17 |
News Archive
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
For her research on the development of hematological and musculoskeletal disorders, Dr. Cornelia Lee-Thedieck, scientist at Karlsruhe Institute of Technology, is awarded an ERC Starting Grant: The European Research Council decided to fund her project "bloodANDbone" with EUR 1.5 million for five years. At KIT's Institute of Functional Interfaces, Lee-Thedieck develops models of the human bone marrow to study the regeneration of blood and bone by stem cells and how this regeneration is disturbed in diseases like leukemia or bone metastases.
Current disinfectant products for killing viruses like coronavirus take minutes to fully sanitize surfaces, which isn't practical on high-contact areas such as door handles, elevators and bannisters.
› Verified 3 days ago
| Entity Name | Saint Lukes Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841295557 PECOS PAC ID: 1456376599 Enrollment ID: O20051007000794 |
News Archive
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
For her research on the development of hematological and musculoskeletal disorders, Dr. Cornelia Lee-Thedieck, scientist at Karlsruhe Institute of Technology, is awarded an ERC Starting Grant: The European Research Council decided to fund her project "bloodANDbone" with EUR 1.5 million for five years. At KIT's Institute of Functional Interfaces, Lee-Thedieck develops models of the human bone marrow to study the regeneration of blood and bone by stem cells and how this regeneration is disturbed in diseases like leukemia or bone metastases.
Current disinfectant products for killing viruses like coronavirus take minutes to fully sanitize surfaces, which isn't practical on high-contact areas such as door handles, elevators and bannisters.
› Verified 3 days ago
| Entity Name | Anesthesia Providers Group, P.s.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962731745 PECOS PAC ID: 1052590270 Enrollment ID: O20110120000394 |
News Archive
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
For her research on the development of hematological and musculoskeletal disorders, Dr. Cornelia Lee-Thedieck, scientist at Karlsruhe Institute of Technology, is awarded an ERC Starting Grant: The European Research Council decided to fund her project "bloodANDbone" with EUR 1.5 million for five years. At KIT's Institute of Functional Interfaces, Lee-Thedieck develops models of the human bone marrow to study the regeneration of blood and bone by stem cells and how this regeneration is disturbed in diseases like leukemia or bone metastases.
Current disinfectant products for killing viruses like coronavirus take minutes to fully sanitize surfaces, which isn't practical on high-contact areas such as door handles, elevators and bannisters.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luis F Beaz Rivera, MD Mansion Real, Calle Rey Fernando 129, Cotto Laurel, PR 00780 Ph: (787) 840-4117 | Dr Luis F Beaz Rivera, MD Mansion Real, Calle Rey Fernando 129, Cotto Laurel, PR 00780 Ph: (787) 812-3571 |
News Archive
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
For her research on the development of hematological and musculoskeletal disorders, Dr. Cornelia Lee-Thedieck, scientist at Karlsruhe Institute of Technology, is awarded an ERC Starting Grant: The European Research Council decided to fund her project "bloodANDbone" with EUR 1.5 million for five years. At KIT's Institute of Functional Interfaces, Lee-Thedieck develops models of the human bone marrow to study the regeneration of blood and bone by stem cells and how this regeneration is disturbed in diseases like leukemia or bone metastases.
Current disinfectant products for killing viruses like coronavirus take minutes to fully sanitize surfaces, which isn't practical on high-contact areas such as door handles, elevators and bannisters.
› Verified 3 days ago